Integrated BioPharma's market cap is currently $9.16M. The company's EPS TTM is $-0.006; its P/E ratio is 12.06; Integrated BioPharma is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
